Uber India partners with fintech company Moove to improve driver participationThe startup offers accessible vehicle financing exclusively to drivers on the Uber's platform.
Series A2 round gets Moove $105 million in fundingMoove has raised $105 mn for scaling the vehicle financing all around MENA, Europe, and Asia. Moove is a fintech in Africa and provides fin...
Honda sues Hero Electric over e-scooter designThe Japanese manufacturer, in its petition seeking an ad interim injunction against Hero Electric, has alleged that the Indian company was ...
RB to expand market share in pain relief segmentThe pain relief market is estimated to be around Rs 4,200 crore, which includes all forms of products in cream, gel, spray and balm.
PV Sindhu is now the no. 2 player in endorsementsThe 21-year old, who won a silver medal at the Rio Olympics last summer, now stands second on the leader-board of Indian sports-earners for...
Emami Zandu Balm wins disparagement case against RB’s MoovEmami challenged the product superiority claim made by RB at the Alipore District Court in Kolkata for infringement and disparagement.
SC rejects Reckitt Benckiser ad claims for Moov; Emami wins disparagement caseThe Supreme Court has upheld Kolkata-based consumer goods firm Emami’s allegations against Reckitt Benckiser (RB)'s ad for its pain balm Mo...
Former Paras co-promoter launches personal care brand Layer'rFormer Paras Pharma co-promoter Devendra Patel is back in the Rs 30,000 cr personal care market with his new brand Layer’r.
- Marico buys up personal care brands of Paras Pharmaceuticals from Reckitt Benckiser
Marico today acquired a part of the personal care business from Reckitt Benckiser India, which the domestic arm of the British major had bo...
- Paras fought a dozen copyright cases every year
Since the days of its first successful product Stopache in the ‘80s, Paras Pharmaceuticals has seen copycats aping its flagship brands.
- Paras' MENA report card lured Reckitt
Mena factor is emerging as the draw for multinational suitors looking for Indian companies, the recent Paras Pharma buyout by Reckitt Benck...
- From Paras to PE fund, Patel on the Moov
Barely two days after he sold off Paras Pharmaceuticals, Girish Patel is back to what he does best—building enterprise.
- Paras deal a big shock for us: Emami
It is an absolute shock,” says Emami Executive Chairman RS Agarwal about his company losing out to Reckitt Benckiser in the race to buy Par...
- Brand power may steer Paras deal at high valuation
Paras Pharmaceuticals look for suitors seeking Rs 3,500 crore, thus valuing the OTC major eight times its turnover.
- 'I will create another Moov & DermiCool'
Darshan Patel, the man behind Paras says, moving away from his brands was painful.
- Actis to buy 10% in Paras for Rs 100 cr
Private equity major Actis is close to picking up 10% in the Ahmedabad-based Paras Pharmaceuticals, the company that owns well known brands...
- Paras looks to buy int’l OTC brands
Paras Pharmaceuticals iwants to acquire brands, or OTC companies, that would fit in with its growth plans.